Clinically, genetic profiling of 603 HCC patients illustrates that either Wnt/β-actin pathway or Myc/Akt pathway is abnormally activated, which is parallel with TGFβ overexpression (150). This evidence concerns the gene AKT1 and hepatocellular carcinoma.